BACKGROUND: Childhood cancer survivors are at risk for long-term neurocognitive and psychosocial morbidities. Research has seldom examined the relationship between these morbidities; thus, little empirical evidence exists concerning overall salience and how morbidities converge to impair day-to-day functioning. An increased understanding of functional impairment resulting from the pediatric cancer experience can inform early risk identification as well as sources for intervention. The purpose of this study was to characterize the frequency/severity of functional impairment and identify significant neurocognitive and psychosocial determinants of functional impairment. METHODS: Fifty child-parent dyads were enrolled. Children were aged 7-19 years who were at least 2 years postdiagnosis with leukemia/lymphoma and were recruited through a pediatric oncology late effects clinic. Parents completed questionnaires, rating their own adjustment to their child's illness as well as their child's level of functional impairment, while a brief neuropsychological exam was administered to children. RESULTS: Twenty-six percent of the sample evidenced clinically significant functional impairment. Regression analyses indicated that neurocognitive deficits did not predict functional impairment, whereas parental stress was a significant predictor. CONCLUSIONS: Although children demonstrated both neurocognitive deficits and functional impairments, results favor psychosocial factors, such as parental stress, as a predictor of overall functional impairment. The implications of this study suggest that late effects aggregate to impact day-to-day functioning in pediatric cancer survivor populations and parental stress may serve as a marker for heightened risk. The results suggest that broader functional domains, especially school and self-care domains, should be evaluated and considered when identifying potential targets for psychosocial interventions.
BACKGROUND: Childhood cancer survivors are at risk for long-term neurocognitive and psychosocial morbidities. Research has seldom examined the relationship between these morbidities; thus, little empirical evidence exists concerning overall salience and how morbidities converge to impair day-to-day functioning. An increased understanding of functional impairment resulting from the pediatric cancer experience can inform early risk identification as well as sources for intervention. The purpose of this study was to characterize the frequency/severity of functional impairment and identify significant neurocognitive and psychosocial determinants of functional impairment. METHODS: Fifty child-parent dyads were enrolled. Children were aged 7-19 years who were at least 2 years postdiagnosis with leukemia/lymphoma and were recruited through a pediatric oncology late effects clinic. Parents completed questionnaires, rating their own adjustment to their child's illness as well as their child's level of functional impairment, while a brief neuropsychological exam was administered to children. RESULTS: Twenty-six percent of the sample evidenced clinically significant functional impairment. Regression analyses indicated that neurocognitive deficits did not predict functional impairment, whereas parental stress was a significant predictor. CONCLUSIONS: Although children demonstrated both neurocognitive deficits and functional impairments, results favor psychosocial factors, such as parental stress, as a predictor of overall functional impairment. The implications of this study suggest that late effects aggregate to impact day-to-day functioning in pediatric cancer survivor populations and parental stress may serve as a marker for heightened risk. The results suggest that broader functional domains, especially school and self-care domains, should be evaluated and considered when identifying potential targets for psychosocial interventions.
Authors: Melissa K Cousino; Rebecca Hazen; Katherine Leigh Josie; Kelly Laschinger; Peter de Blank; H Gerry Taylor Journal: J Clin Psychol Med Settings Date: 2017-12
Authors: Christina M Sharkey; Ashley H Clawson; Larry L Mullins; Tara M Brinkman; Ching-Hon Pui; Melissa M Hudson; Kevin R Krull Journal: Pediatr Blood Cancer Date: 2019-04-29 Impact factor: 3.167
Authors: Andrew Garas; Louise A McLean; Cinzia R De Luca; Peter Downie; Maria C McCarthy Journal: Support Care Cancer Date: 2019-03-21 Impact factor: 3.603
Authors: Victoria W Willard; Ibrahim Qaddoumi; Hui Zhang; Lu Huang; Kathryn M Russell; Rachel Brennan; Matthew W Wilson; Carlos Rodriguez-Galindo; Sean Phipps Journal: Pediatr Blood Cancer Date: 2016-11-03 Impact factor: 3.167
Authors: Anao Zhang; QingYing Ji; Jennifer Currin-McCulloch; Phyllis Solomon; YuTing Chen; Yaxi Li; Barbara Jones; Cynthia Franklin; Jack Nowicki Journal: Support Care Cancer Date: 2018-03-15 Impact factor: 3.603
Authors: I-Chan Huang; Tara M Brinkman; Larry Mullins; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Kevin R Krull Journal: Psychooncology Date: 2018-06-29 Impact factor: 3.894
Authors: Christina K Ullrich; Angie Mae Rodday; Kristin Bingen; Mary Jo Kupst; Sunita K Patel; Karen L Syrjala; Lynnette L Harris; Christopher J Recklitis; Lisa Schwartz; Stella Davies; Eva C Guinan; Grace Chang; Joanne Wolfe; Susan K Parsons Journal: Biol Blood Marrow Transplant Date: 2015-09-05 Impact factor: 5.742